{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:38:18Z","timestamp":1782513498937,"version":"3.54.5"},"reference-count":160,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.pharma.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T05:01:16Z","timestamp":1707800476000},"page":"373-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"82","author":[{"given":"Bitasta","family":"Mandal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.pharma.2024.02.005_bib0805","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.3390\/nu7115454","article-title":"Nutritional modulation of non-alcoholic fatty liver disease and insulin resistance","volume":"7","author":"Yki-J\u00e4rvinen","year":"2015","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib0810","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3390\/ijerph19042096","article-title":"Prevalence and risk factors of metabolic-associated fatty liver disease among 73,566 individuals in Beijing, China","volume":"19","author":"Yuan","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.pharma.2024.02.005_bib0815","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/1319-3767.153812","article-title":"Nonalcoholic fatty liver disease: noninvasive methods of diagnosing hepatic steatosis","volume":"21","author":"AlShaalan","year":"2015","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.pharma.2024.02.005_bib0820","series-title":"Non-alcoholic fatty liver disease (NAFLD): assessment and management","year":"2016"},{"issue":"39","key":"10.1016\/j.pharma.2024.02.005_bib0825","doi-asserted-by":"crossref","first-page":"14172","DOI":"10.3748\/wjg.v20.i39.14172","article-title":"Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"20","author":"Kelley","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pharma.2024.02.005_bib0830","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent insights into the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib0835","first-page":"9","article-title":"Non alcoholic fatty liver disease and metabolic syndrome","volume":"13","author":"Paschos","year":"2009","journal-title":"Hippokratia"},{"issue":"6","key":"10.1016\/j.pharma.2024.02.005_bib0840","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1155\/2012\/725468","article-title":"Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"26","author":"Beaton","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.pharma.2024.02.005_bib0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-018-2160-6","article-title":"Why people use herbal medicine: insights from a focus-group study in Germany","volume":"18","author":"Welz","year":"2018","journal-title":"BMC Complement Altern Med"},{"issue":"8","key":"10.1016\/j.pharma.2024.02.005_bib0850","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/ptr.5642","article-title":"Chemistry, pharmacology and health benefits of anthocyanins","volume":"30","author":"Smeriglio","year":"2016","journal-title":"Phytother Res"},{"issue":"8","key":"10.1016\/j.pharma.2024.02.005_bib0855","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.3390\/nu13082831","article-title":"A review of the properties of anthocyanins and their influence on factors affecting cardiometabolic and cognitive health","volume":"13","author":"Ockermann","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.pharma.2024.02.005_bib0860","doi-asserted-by":"crossref","first-page":"145421","DOI":"10.1155\/2013\/145421","article-title":"Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease","volume":"2013","author":"Valenti","year":"2013","journal-title":"Oxid Med Cell Longev"},{"issue":"17","key":"10.1016\/j.pharma.2024.02.005_bib0865","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.3390\/molecules25173809","article-title":"Anthocyanins: a comprehensive review of their chemical properties and health effects on cardiovascular and neurodegenerative diseases","volume":"25","author":"Mattioli","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib0870","doi-asserted-by":"crossref","first-page":"1361779","DOI":"10.1080\/16546628.2017.1361779","article-title":"Anthocyanidins and anthocyanins: colored pigments as food, pharmaceutical ingredients, and the potential health benefits","volume":"61","author":"Khoo","year":"2017","journal-title":"Food Nutr Res"},{"issue":"10290","key":"10.1016\/j.pharma.2024.02.005_bib0875","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.pharma.2024.02.005_bib0880","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/10408363.2011.596521","article-title":"Non-alcoholic fatty liver disease","volume":"48","author":"Smith","year":"2011","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.pharma.2024.02.005_bib0885","series-title":"Nonalcoholic fatty liver","author":"Kudaravalli","year":"2022"},{"key":"10.1016\/j.pharma.2024.02.005_bib0890","doi-asserted-by":"crossref","first-page":"639548","DOI":"10.3389\/fendo.2021.639548","article-title":"Non-alcoholic fatty liver disease in obese youth with insulin resistance and type 2 diabetes","volume":"12","author":"Scapaticci","year":"2021","journal-title":"Front Endocrinol"},{"issue":"16","key":"10.1016\/j.pharma.2024.02.005_bib0895","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib0900","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000282080","article-title":"Epidemiology of non-alcoholic fatty liver disease","volume":"28","author":"Bellentani","year":"2010","journal-title":"Dig Dis"},{"issue":"2","key":"10.1016\/j.pharma.2024.02.005_bib0905","doi-asserted-by":"crossref","first-page":"99","DOI":"10.30699\/ijp.2017.25038","article-title":"Clinical manifestations and diagnosis of nonalcoholic fatty liver disease","volume":"12","author":"Khoonsari","year":"2017","journal-title":"Iran J Pathol"},{"issue":"22","key":"10.1016\/j.pharma.2024.02.005_bib0910","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.pharma.2024.02.005_bib0915","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1046\/j.1440-1746.2002.02881.x","article-title":"Non-alcoholic fatty liver disease: an overview","volume":"17","author":"Mulhall","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.pharma.2024.02.005_bib0920","series-title":"Handbook of liver disease","author":"Friedman","year":"2017"},{"issue":"5","key":"10.1016\/j.pharma.2024.02.005_bib0925","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/nu13051442","article-title":"Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food consumption and other dietary components in its development","volume":"13","author":"Lujan","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.pharma.2024.02.005_bib0930","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/1570161115666170621075157","article-title":"Nonalcoholic fatty liver disease vs. nonalcoholic steatohepatitis: pathological and clinical implications","volume":"16","author":"Boutari","year":"2018","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib0935","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u00a0\u2014\u00a0meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.pharma.2024.02.005_bib0940","series-title":"Steatohepatitis: a tale of two \u201chits\u201d?","author":"Day","year":"1998"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib0945","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.gastro.2005.11.017","article-title":"From fat to inflammation","volume":"130","author":"Day","year":"2006","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.pharma.2024.02.005_bib0950","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3390\/biology11081237","article-title":"Adipokines in non-alcoholic fatty liver disease: are we on the road toward new biomarkers and therapeutic targets?","volume":"11","author":"Francisco","year":"2022","journal-title":"Biology"},{"issue":"3","key":"10.1016\/j.pharma.2024.02.005_bib0955","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.pharma.2024.02.005_bib0960","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib0965","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/00365520701559003","article-title":"Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet","volume":"43","author":"Machado","year":"2008","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.pharma.2024.02.005_bib0970","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2004.11.043","article-title":"Hyperlipidemic effects of dietary saturated fats mediated through PGC-1\u03b2 coactivation of SREBP","volume":"120","author":"Lin","year":"2005","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib0975","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0002-9440(10)63489-X","article-title":"Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease","volume":"163","author":"Roskams","year":"2003","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib0980","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0028-1091981","article-title":"Mechanisms of disease progression in nonalcoholic fatty liver disease","volume":"28","author":"Jou","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.pharma.2024.02.005_bib0985","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in nonalcoholic fatty liver disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.pharma.2024.02.005_bib0990","doi-asserted-by":"crossref","first-page":"2862173","DOI":"10.1155\/2016\/2862173","article-title":"The pathogenesis of nonalcoholic fatty liver disease: interplay between diet, gut microbiota, and genetic background","volume":"2016","author":"Yu","year":"2016","journal-title":"Gastroenterol Res Pract"},{"issue":"9","key":"10.1016\/j.pharma.2024.02.005_bib0995","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","article-title":"Recent insights on the role of cholesterol in non-alcoholic fatty liver disease","volume":"1852","author":"Arguello","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"17","key":"10.1016\/j.pharma.2024.02.005_bib1000","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1074\/jbc.M510660200","article-title":"Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis","volume":"281","author":"Malhi","year":"2006","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib1005","doi-asserted-by":"crossref","first-page":"G270","DOI":"10.1152\/ajpgi.00304.2014","article-title":"Hepatic TLR4 signaling in obese NAFLD","volume":"309","author":"Sharifnia","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-2006-960170","article-title":"Genetics of alcoholic liver disease and nonalcoholic fatty liver disease","volume":"27","author":"de Alwis","year":"2007","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.pharma.2024.02.005_bib1015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0168-8278(03)00459-8","article-title":"Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese","volume":"39","author":"Dixon","year":"2003","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.pharma.2024.02.005_bib1020","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1478-3231.2009.01988.x","article-title":"Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease","volume":"29","author":"Yoneda","year":"2009","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.14218\/JCTH.2018.00008","article-title":"Fatty liver disease and gut microbiota: a comprehensive update","volume":"7","author":"Campo","year":"2019","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"10.1016\/j.pharma.2024.02.005_bib1030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/ijms17030300","article-title":"Gut microbiota and nonalcoholic fatty liver disease: insights on mechanism and application of metabolomics","volume":"17","author":"He","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.pharma.2024.02.005_bib1035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2337\/diabetes.54.3.603","article-title":"Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes","volume":"54","author":"Petersen","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1040","first-page":"19","article-title":"Current management of NAFLD","volume":"89","author":"Munteanu","year":"2016","journal-title":"Clujul Med"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.pharma.2024.02.005_bib1050","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1053\/j.gastro.2009.03.019","article-title":"High or low carbohydrate diets: which is better for weight loss, insulin resistance and fatty livers?","volume":"136","author":"Boden","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1055","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.pharma.2024.02.005_bib1060","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.pharma.2024.02.005_bib1065","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/medicina55050166","article-title":"Dietary and pharmacological treatment of nonalcoholic fatty liver disease","volume":"55","author":"Jeznach-Steinhagen","year":"2019","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1070","first-page":"35","article-title":"Nonalcoholic fatty liver disease: diagnosis and management","volume":"88","author":"Wilkins","year":"2013","journal-title":"Am Fam Physician"},{"issue":"1.\u00a0Suppl","key":"10.1016\/j.pharma.2024.02.005_bib1075","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jhep.2015.02.041","article-title":"Current efforts and trends in the treatment of NASH","volume":"62","author":"Ratziu","year":"2015","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jhep.2012.02.023","article-title":"Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"57","author":"Keating","year":"2012","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.pharma.2024.02.005_bib1085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","article-title":"Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients","volume":"149","author":"Lassailly","year":"2015","journal-title":"Gastroenterology"},{"issue":"30","key":"10.1016\/j.pharma.2024.02.005_bib1090","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"16","key":"10.1016\/j.pharma.2024.02.005_bib1095","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-014-0336-5","article-title":"Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial","volume":"47","author":"Sharifi","year":"2014","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib1105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/ph11040121","article-title":"Antidiabetic drugs in NAFLD: the accomplishment of two goals at once?","volume":"11","author":"Tacelli","year":"2018","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.pharma.2024.02.005_bib1110","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jhep.2015.11.031","article-title":"Time for glucagon like peptide-1 receptor agonists treatment for patients with NAFLD?","volume":"64","author":"Gastaldelli","year":"2016","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.pharma.2024.02.005_bib1115","first-page":"MS6","article-title":"Safety and efficacy of combined ezetimibe\/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease","volume":"15","author":"Abel","year":"2009","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib1120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/diseases6040087","article-title":"Judicious use of lipid lowering agents in the management of NAFLD","volume":"6","author":"Iqbal","year":"2018","journal-title":"Diseases"},{"issue":"5","key":"10.1016\/j.pharma.2024.02.005_bib1125","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.24544","article-title":"Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial","volume":"54","author":"Zein","year":"2011","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.pharma.2024.02.005_bib1130","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/dom.12309","article-title":"CCR2 antagonism in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study","volume":"16","author":"Di Prospero","year":"2014","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.pharma.2024.02.005_bib1135","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J Gastroenterol"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib1140","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/ph11040104","article-title":"Obeticholic acid: a new era in the treatment of nonalcoholic fatty liver disease","volume":"11","author":"Abenavoli","year":"2018","journal-title":"Pharmaceuticals"},{"issue":"22","key":"10.1016\/j.pharma.2024.02.005_bib1145","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.3390\/ijerph16224334","article-title":"Pharmacological therapy of non-alcoholic fatty liver disease: what drugs are available now and future perspectives","volume":"16","author":"Pennisi","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"12","key":"10.1016\/j.pharma.2024.02.005_bib1150","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.cgh.2017.04.016","article-title":"A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis","volume":"15","author":"Kheong","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib1155","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3390\/ijms23042149","article-title":"Anthocyanins: traditional uses, structural and functional variations, approaches to increase yields and products\u2019 quality, hepatoprotection, liver longevity, and commercial products","volume":"23","author":"Mohammed","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib1160","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.foodchem.2008.09.001","article-title":"Chemical studies of anthocyanins: a review","volume":"113","author":"Casta\u00f1eda-Ovando","year":"2009","journal-title":"Food Chem"},{"key":"10.1016\/j.pharma.2024.02.005_bib1165","series-title":"Encyclopedia of food chemistry","author":"Varelis","year":"2018"},{"issue":"9","key":"10.1016\/j.pharma.2024.02.005_bib1170","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tifs.2005.03.019","article-title":"Tracking color and pigment changes in anthocyanin products","volume":"16","author":"Wrolstad","year":"2005","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.pharma.2024.02.005_bib1175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.food.080708.100754","article-title":"Anthocyanins: natural colorants with health-promoting properties","volume":"1","author":"He","year":"2010","journal-title":"Annu Rev Food Sci Technol"},{"issue":"9","key":"10.1016\/j.pharma.2024.02.005_bib1180","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/biomedicines8090336","article-title":"Anthocyanins, vibrant color pigments, and their role in skin cancer prevention","volume":"8","author":"Diaconeasa","year":"2020","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.pharma.2024.02.005_bib1185","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0031-9422(03)00438-2","article-title":"Analysis and biological activities of anthocyanins","volume":"64","author":"Kong","year":"2003","journal-title":"Phytochemistry"},{"issue":"15","key":"10.1016\/j.pharma.2024.02.005_bib1190","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jacc.2009.11.075","article-title":"Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk in the atherosclerosis risk in communities (ARIC) study","volume":"55","author":"Nambi","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.pharma.2024.02.005_bib1195","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1039\/C9FO00515C","article-title":"Antidiabetic effects of extracts of red and yellow fruits of cornelian cherries (Cornus mas L.) on rats with streptozotocin-induced diabetes mellitus","volume":"10","author":"Dzydzan","year":"2019","journal-title":"Food Funct"},{"issue":"11","key":"10.1016\/j.pharma.2024.02.005_bib1200","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.3390\/foods10112813","article-title":"Characterization of soybean protein isolate-food polyphenol interaction via virtual screening and experimental studies","volume":"10","author":"Ao","year":"2021","journal-title":"Foods"},{"key":"10.1016\/j.pharma.2024.02.005_bib1205","doi-asserted-by":"crossref","first-page":"23634","DOI":"10.1038\/srep23634","article-title":"3D-QSAR and docking studies of flavonoids as potent Escherichia coli inhibitors","volume":"6","author":"Fang","year":"2016","journal-title":"Sci Rep"},{"issue":"13","key":"10.1016\/j.pharma.2024.02.005_bib1210","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.3390\/molecules27134193","article-title":"Cornelian cherry (Cornus mas L.) extracts exert cytotoxicity in two selected melanoma cell lines\u00a0\u2014\u00a0a factorial analysis of time-dependent alterations in values obtained with SRB and MTT assays","volume":"27","author":"Lewandowski","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.pharma.2024.02.005_bib1215","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.postharvbio.2017.01.016","article-title":"Non-destructive prediction of soluble solids and dry matter content using NIR spectroscopy and its relationship with sensory quality in sweet cherries","volume":"128","author":"Escribano","year":"2017","journal-title":"Postharvest Biol Technol"},{"key":"10.1016\/j.pharma.2024.02.005_bib1220","doi-asserted-by":"crossref","first-page":"4825949","DOI":"10.1155\/2019\/4825949","article-title":"Cherry anthocyanins regulate NAFLD by promoting autophagy pathway","volume":"2019","author":"Chu","year":"2019","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"10.1016\/j.pharma.2024.02.005_bib1225","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2014.12.016","article-title":"Prevalence of blueberry allergy in a Turkish population","volume":"114","author":"Dereci","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pharma.2024.02.005_bib1230","series-title":"Warfarin","author":"Patel","year":"2023"},{"issue":"9","key":"10.1016\/j.pharma.2024.02.005_bib1235","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1021\/jf405272b","article-title":"Correlation between species-specific metabolite profiles and bioactivities of blueberries (Vaccinium spp.)","volume":"62","author":"Lee","year":"2014","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.pharma.2024.02.005_bib1240","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.exer.2016.01.012","article-title":"Quercetin glycosides and chlorogenic acid in highbush blueberry leaf decoction prevent cataractogenesis in vivo and in vitro: investigation of the effect on calpains, antioxidant and metal chelating properties","volume":"145","author":"Ferlemi","year":"2016","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.pharma.2024.02.005_bib1245","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.3390\/ijms21072605","article-title":"Anti-inflammatory drugs as anticancer agents","volume":"21","author":"Zappavigna","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.pharma.2024.02.005_bib1250","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00240-017-0999-5","article-title":"Vitamin B6 intake and the risk of incident kidney stones","volume":"46","author":"Ferraro","year":"2018","journal-title":"Urolithiasis"},{"key":"10.1016\/j.pharma.2024.02.005_bib1255","first-page":"121","article-title":"Low glycemic index noodle snack from yellow sweet potato (Ipomoea batatas) and pumpkin (Cucurbita moschata) blend","volume":"1","author":"Saputrie","year":"2017","journal-title":"Int Conf Transl Med Health Sci"},{"issue":"5","key":"10.1016\/j.pharma.2024.02.005_bib1260","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1021\/jo902670z","article-title":"Linear and v-shaped nonlinear optical chromophores with multiple 4H-pyran-4-ylidene moieties","volume":"75","author":"Andreu","year":"2010","journal-title":"J Org Chem"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib1265","first-page":"326","article-title":"In vivo anti-fatigue activity of total flavonoids from sweetpotato [Ipomoea batatas (L.) Lam.] leaf in mice","volume":"50","author":"Li","year":"2013","journal-title":"Indian J Biochem Biophys"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib1270","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3390\/nu5041169","article-title":"Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health","volume":"5","author":"Abdel-Aal","year":"2013","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1275","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7454\/mss.v19i1.4476","article-title":"Flavonoid compounds from the bark of Aglaia eximia (Meliaceae)","volume":"19","author":"Sianturi","year":"2015","journal-title":"Makara J Sci"},{"key":"10.1016\/j.pharma.2024.02.005_bib1280","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcs.2015.05.003","article-title":"Identification of anthocyanins in black rice (Oryza sativa L.) by UPLC\/Q-TOF-MS and their in\u00a0vitro and in\u00a0vivo antioxidant activities","volume":"64","author":"Hao","year":"2015","journal-title":"J Cereal Sci"},{"key":"10.1016\/j.pharma.2024.02.005_bib1285","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jep.2016.09.004","article-title":"Evaluation of acute toxicity, genotoxicity and inhibitory effect on acute inflammation of an ethanol extract of Morus alba L.\u00a0(Moraceae) in mice","volume":"194","author":"Oliveira","year":"2016","journal-title":"J Ehnopharmacol"},{"key":"10.1016\/j.pharma.2024.02.005_bib1290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12948-020-00116-7","article-title":"Allergic reactions to genus Morus plants: a review","volume":"18","author":"Papia","year":"2020","journal-title":"Clin Mol Allergy"},{"issue":"12","key":"10.1016\/j.pharma.2024.02.005_bib1295","first-page":"12","article-title":"Mulberry (Morus alba L.): risk of herb-drug interactions via alteration of phase I and II metabolizing enzymes and transporters in HepG2 cells","volume":"12","author":"Udomsak","year":"2022","journal-title":"J Appl Pharm Sci"},{"issue":"9","key":"10.1016\/j.pharma.2024.02.005_bib1300","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3390\/antiox11091764","article-title":"Identification and antioxidant capacity of free and bound phenolics in six varieties of mulberry seeds using UPLC-ESI-QTOF-MS\/MS","volume":"11","author":"Gao","year":"2022","journal-title":"Antioxidants"},{"issue":"46","key":"10.1016\/j.pharma.2024.02.005_bib1305","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/0973-1296.177910","article-title":"In vitro and in vivo antioxidant activity of flavonoid extracted from mulberry fruit (Morus alba L.)","volume":"12","author":"Raman","year":"2016","journal-title":"Pharmacogn Mag"},{"issue":"8","key":"10.1016\/j.pharma.2024.02.005_bib1310","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1039\/c2fo30058c","article-title":"The health benefits of blackcurrants","volume":"3","author":"Gopalan","year":"2012","journal-title":"Food Funct"},{"key":"10.1016\/j.pharma.2024.02.005_bib1315","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.freeradbiomed.2014.04.006","article-title":"Lowering of oxidative stress improves endothelial function in healthy subjects with habitually low intake of fruit and vegetables: a randomized controlled trial of antioxidant-and polyphenol-rich blackcurrant juice","volume":"72","author":"Khan","year":"2014","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.pharma.2024.02.005_bib1320","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/1090820X12438913","article-title":"Bleeding risks of herbal, homeopathic, and dietary supplements: a hidden nightmare for plastic surgeons?","volume":"32","author":"Wong","year":"2012","journal-title":"Aesthet Surg J"},{"issue":"28","key":"10.1016\/j.pharma.2024.02.005_bib1325","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.1021\/acs.jafc.8b02070","article-title":"Profiles of volatile compounds in blackcurrant (Ribes nigrum) cultivars with a special focus on the influence of growth latitude and weather conditions","volume":"66","author":"Marsol-Vall","year":"2018","journal-title":"J Agric Food Chem"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1330","first-page":"29","article-title":"Antifungal activity of some plant extracts against Botrytis cinerea Pers. in the blackcurrant crop (Ribes nigrum L.)","volume":"14","author":"\u015eesan","year":"2015","journal-title":"Acta Sci Pol Hortorum Cultus"},{"issue":"10","key":"10.1016\/j.pharma.2024.02.005_bib1335","first-page":"CD001321","article-title":"Cranberries for preventing urinary tract infections","volume":"10","author":"Jepson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.pharma.2024.02.005_bib1340","doi-asserted-by":"crossref","first-page":"103374","DOI":"10.1016\/j.sjbs.2022.103374","article-title":"Magnification of the therapeutic uses of pomegranate fruits and peel in rats injected with carbon tetrachloride (CCl4)","volume":"29","author":"Saad Mohammed Abd Elmeged","year":"2022","journal-title":"Saudi J Biol Sci"},{"key":"10.1016\/j.pharma.2024.02.005_bib1345","doi-asserted-by":"crossref","first-page":"112889","DOI":"10.1016\/j.jep.2020.112889","article-title":"Antiadhesive natural products against uropathogenic E.\u00a0coli: what can we learn from cranberry extract?","volume":"257","author":"Scharf","year":"2020","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib1350","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1469-0691.2007.01917.x","article-title":"In vitro and in vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules","volume":"14","author":"Lavigne","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib1355","first-page":"421","article-title":"Drug interactions due to cytochrome P450","volume":"13","author":"Ogu","year":"2000","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"5","key":"10.1016\/j.pharma.2024.02.005_bib1360","doi-asserted-by":"crossref","first-page":"e0196438","DOI":"10.1371\/journal.pone.0196438","article-title":"An overview of technical considerations when using quantitative real-time PCR analysis of gene expression in human exercise research","volume":"13","author":"Kuang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharma.2024.02.005_bib1365","doi-asserted-by":"crossref","first-page":"8626987","DOI":"10.1155\/2016\/8626987","article-title":"Punica granatum L.\u00a0(pomegranate) extract: in vivo study of antimicrobial activity against Porphyromonas gingivalis in Galleria mellonella model","volume":"2016","author":"Aparecida Proc\u00f3pio Gomes","year":"2016","journal-title":"Sci World J"},{"key":"10.1016\/j.pharma.2024.02.005_bib1370","doi-asserted-by":"crossref","first-page":"8574541","DOI":"10.1155\/2022\/8574541","article-title":"Pomegranate (Punica granatum) peel inhibits the in vitro and in vivo growth of piroplasm parasites","volume":"2022","author":"Eltaysh","year":"2022","journal-title":"J Parasitol Res"},{"issue":"5","key":"10.1016\/j.pharma.2024.02.005_bib1375","first-page":"1","article-title":"Studies on the therapeutic properties of roselle (Hibiscus sabdariffa) calyx: a popular ingredient in the cuisine of North East India","volume":"2","author":"Puro","year":"2017","journal-title":"Int J Food Sci Nutr"},{"issue":"5","key":"10.1016\/j.pharma.2024.02.005_bib1380","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/biomedicines8050100","article-title":"Organic acids from roselle (Hibiscus sabdariffa L.)\u00a0\u2014\u00a0a brief review of its pharmacological effects","volume":"8","author":"Izquierdo-Vega","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.pharma.2024.02.005_bib1385","doi-asserted-by":"crossref","first-page":"5013898","DOI":"10.1155\/2020\/5013898","article-title":"Pharmacokinetic herb-drug interaction between Hibiscus sabdariffa calyces aqueous extract and captopril in rats","volume":"2020","author":"Nurfaradilla","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"10.1016\/j.pharma.2024.02.005_bib1390","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/07391102.2021.2009914","article-title":"Hibiscus sabdariffa anthocyanins are potential modulators of estrogen receptor alpha activity with favourable toxicology: a computational analysis using molecular docking, ADME\/Tox prediction, 2D\/3D QSAR and molecular dynamics simulation","volume":"41","author":"Laskar","year":"2023","journal-title":"J Biomol Struct Dyn"},{"issue":"OCE2","key":"10.1016\/j.pharma.2024.02.005_bib1395","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1017\/S0029665119000855","article-title":"In vitro and in vivo anti-diabetic properties of Hibiscus sabdariffa","volume":"78","author":"Zulfiqar","year":"2019","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.pharma.2024.02.005_bib1400","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jfca.2014.12.016","article-title":"Iridoids and anthocyanins in cornelian cherry (Cornus mas L.) cultivars","volume":"40","author":"Kucharska","year":"2015","journal-title":"J Food Compos Anal"},{"key":"10.1016\/j.pharma.2024.02.005_bib1405","first-page":"91","article-title":"Hepatoprotective effect of Cornus mas fruits extract on serum biomarkers in methotrexate-induced liver injury in male rats","volume":"1","author":"Saei","year":"2016","journal-title":"Pharmacologyonline"},{"issue":"2","key":"10.1016\/j.pharma.2024.02.005_bib1410","doi-asserted-by":"crossref","first-page":"e17625","DOI":"10.5812\/thrita.17624","article-title":"Hepatoprotective effect of Cornus mas fruits extract against carbon tetrachloride-induced hepatic damage in male albino rats","volume":"3","author":"Somi","year":"2014","journal-title":"Thrita"},{"issue":"3","key":"10.1016\/j.pharma.2024.02.005_bib1415","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/nu10030368","article-title":"A review of the health benefits of cherries","volume":"10","author":"Kelley","year":"2018","journal-title":"Nutrients"},{"issue":"7\u20138","key":"10.1016\/j.pharma.2024.02.005_bib1420","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.nut.2016.01.007","article-title":"Dietary sweet cherry anthocyanins attenuates diet-induced hepatic steatosis by improving hepatic lipid metabolism in mice","volume":"32","author":"Song","year":"2016","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.pharma.2024.02.005_bib1425","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/09637486.2013.854749","article-title":"Inhibitory effects of sweet cherry anthocyanins on the obesity development in C57BL\/6 mice","volume":"65","author":"Wu","year":"2014","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.pharma.2024.02.005_bib1430","doi-asserted-by":"crossref","first-page":"4825949","DOI":"10.1155\/2019\/4825949","article-title":"Cherry anthocyanins regulate NAFLD by promoting autophagy pathway","volume":"2019","author":"Chu","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.pharma.2024.02.005_bib1435","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jfca.2017.03.006","article-title":"Polyphenols, anthocyanins, and flavonoids contents and the antioxidant capacity of various cultivars of highbush and half-high blueberries","volume":"62","author":"Li","year":"2017","journal-title":"J Food Compos Anal"},{"issue":"12","key":"10.1016\/j.pharma.2024.02.005_bib1440","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1089\/jmf.2010.0292","article-title":"Blueberry intake alters skeletal muscle and adipose tissue peroxisome proliferator-activated receptor activity and reduces insulin resistance in obese rats","volume":"14","author":"Seymour","year":"2011","journal-title":"J Med Food"},{"key":"10.1016\/j.pharma.2024.02.005_bib1445","doi-asserted-by":"crossref","first-page":"469059","DOI":"10.1155\/2014\/469059","article-title":"Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway","volume":"2014","author":"Ren","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.pharma.2024.02.005_bib1450","doi-asserted-by":"crossref","first-page":"153209","DOI":"10.1016\/j.phymed.2020.153209","article-title":"Phytotherapy using blueberry leaf polyphenols to alleviate non-alcoholic fatty liver disease through improving mitochondrial function and oxidative defense","volume":"69","author":"Li","year":"2020","journal-title":"Phytomedicine"},{"issue":"16","key":"10.1016\/j.pharma.2024.02.005_bib1455","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1021\/acs.jafc.0c06695","article-title":"Malvidin-3-O-glucoside from blueberry ameliorates nonalcoholic fatty liver disease by regulating transcription factor EB-mediated lysosomal function and activating the Nrf2\/ARE signaling pathway","volume":"69","author":"Xu","year":"2021","journal-title":"J Agric Food Chem"},{"issue":"12","key":"10.1016\/j.pharma.2024.02.005_bib1460","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1021\/jf3055455","article-title":"Characterization and quantitation of anthocyanins in purple-fleshed sweet potatoes cultivated in Korea by HPLC-DAD and HPLC-ESI-QTOF-MS\/MS","volume":"61","author":"Lee","year":"2013","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.pharma.2024.02.005_bib1465","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.29219\/fnr.v64.1509","article-title":"Purple sweet potato color protects against hepatocyte apoptosis through Sirt1 activation in high-fat-diet-treated mice","volume":"64","author":"Su","year":"2020","journal-title":"Food Nutr Res"},{"issue":"10","key":"10.1016\/j.pharma.2024.02.005_bib1470","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1139\/apnm-2016-0635","article-title":"Attenuation of hepatic steatosis by purple sweet potato colour is associated with blocking Src\/ERK\/C\/EBP\u03b2 signalling in high-fat-diet\u00a0\u2013\u00a0treated mice","volume":"42","author":"Wang","year":"2017","journal-title":"Appl Physiol Nutr Metab"},{"issue":"3","key":"10.1016\/j.pharma.2024.02.005_bib1475","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1016\/j.foodchem.2013.05.100","article-title":"Phytochemical profile of a Japanese black\u00a0\u2013\u00a0purple rice","volume":"141","author":"Pereira-Caro","year":"2013","journal-title":"Food Chem"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1480","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1743-7075-9-27","article-title":"Black rice (Oryza sativa L.) extract attenuates hepatic steatosis in C57BL\/6J mice fed a high-fat diet via fatty acid oxidation","volume":"9","author":"Jang","year":"2012","journal-title":"Nutr Metab"},{"key":"10.1016\/j.pharma.2024.02.005_bib1485","doi-asserted-by":"crossref","first-page":"103605","DOI":"10.1016\/j.jff.2019.103605","article-title":"Black rice (Oryza sativa L.) reduces obesity and improves lipid metabolism in C57BL\/6J mice fed a high-fat diet","volume":"64","author":"Liu","year":"2020","journal-title":"J Funct Foods"},{"issue":"17","key":"10.1016\/j.pharma.2024.02.005_bib1490","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1039\/C7AY00229G","article-title":"Development and validation of green chromatography for the determination of anthocyanins in haskap berry, mulberry and blackberry","volume":"9","author":"Sang","year":"2017","journal-title":"Anal Methods"},{"key":"10.1016\/j.pharma.2024.02.005_bib1495","doi-asserted-by":"crossref","first-page":"8165716","DOI":"10.1155\/2018\/8165716","article-title":"Mulberry fruit extract ameliorates nonalcoholic fatty liver disease (NAFLD) through inhibition of mitochondrial oxidative stress in rats","volume":"2018","author":"Yang","year":"2018","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"10.1016\/j.pharma.2024.02.005_bib1500","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jfda.2017.10.008","article-title":"Mulberry leaf extracts prevent obesity-induced NAFLD with regulating adipocytokines, inflammation and oxidative stress","volume":"26","author":"Peng","year":"2018","journal-title":"J Food Drug Anal"},{"issue":"6","key":"10.1016\/j.pharma.2024.02.005_bib1505","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12263-015-0495-x","article-title":"Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice","volume":"10","author":"Ann","year":"2015","journal-title":"Genes Nutr"},{"issue":"25","key":"10.1016\/j.pharma.2024.02.005_bib1510","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1021\/jf401171k","article-title":"Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance","volume":"61","author":"Chang","year":"2013","journal-title":"J Agric Food Chem"},{"issue":"2","key":"10.1016\/j.pharma.2024.02.005_bib1515","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1556\/018.69.2018.2.5","article-title":"Extractability of polyphenols from black currant, red currant and gooseberry and their antioxidant activity","volume":"69","author":"Laczk\u00f3-Z\u00f6ld","year":"2018","journal-title":"Acta Biol Hung"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1520","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/oby.22353","article-title":"Blackcurrant (Ribes nigrum) prevents obesity-induced nonalcoholic steatohepatitis in mice","volume":"27","author":"Lee","year":"2019","journal-title":"Obesity"},{"issue":"5","key":"10.1016\/j.pharma.2024.02.005_bib1525","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/nu12051541","article-title":"Blackcurrant (Ribes nigrum) extract prevents dyslipidemia and hepatic steatosis in ovariectomized rats","volume":"12","author":"Nanashima","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.pharma.2024.02.005_bib1530","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/jf001211q","article-title":"Identification of procyanidins and anthocyanins in blueberries and cranberries (Vaccinium spp.) using high-performance liquid chromatography\/mass spectrometry","volume":"49","author":"Prior","year":"2001","journal-title":"J Agric Food Chem"},{"issue":"8","key":"10.1016\/j.pharma.2024.02.005_bib1535","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1248\/bpb.b18-00984","article-title":"Cranberry attenuates progression of non-alcoholic fatty liver disease induced by high-fat diet in mice","volume":"42","author":"Shimizu","year":"2019","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pharma.2024.02.005_bib1540","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fphar.2020.00218","article-title":"Hepatoprotective effect of cranberry nutraceutical extract in non-alcoholic fatty liver model in rats: impact on insulin resistance and Nrf-2 expression","volume":"11","author":"Faheem","year":"2020","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib1545","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.foodchem.2011.01.077","article-title":"Composition of anthocyanins in pomegranate flowers and their antioxidant activity","volume":"127","author":"Zhang","year":"2011","journal-title":"Food Chem"},{"issue":"8","key":"10.1016\/j.pharma.2024.02.005_bib1550","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/jsfa.8042","article-title":"Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation","volume":"97","author":"Noori","year":"2017","journal-title":"J Sci Food Agric"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1555","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3746\/pnf.2016.21.1.14","article-title":"Ameliorative effects of pomegranate peel extract against dietary-induced nonalcoholic fatty liver in rats","volume":"21","author":"Al-Shaaibi","year":"2016","journal-title":"Prev Nutr Food Sci"},{"issue":"7","key":"10.1016\/j.pharma.2024.02.005_bib1560","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1021\/acs.jnatprod.5b00958","article-title":"Isolation and characterization of anthocyanins from Hibiscus sabdariffa flowers","volume":"79","author":"Grajeda-Iglesias","year":"2016","journal-title":"J Nat Prod"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1565","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.1038\/s41598-022-11027-9","article-title":"Hibiscus sabdariffa extract improves hepatic steatosis, partially through IRS-1\/Akt and Nrf2 signaling pathways in rats fed a high-fat diet","volume":"12","author":"Prasomthong","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib1570","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1039\/c3fo30270a","article-title":"Hibiscus sabdariffa L.\u00a0aqueous extract attenuates hepatic steatosis through down-regulation of PPAR-\u03b3 and SREBP-1c in diet-induced obese mice","volume":"4","author":"Villalpando-Arteaga","year":"2013","journal-title":"Food Funct"},{"issue":"10","key":"10.1016\/j.pharma.2024.02.005_bib1575","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1002\/ptr.7249","article-title":"The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: a randomized double-blind clinical trial","volume":"35","author":"Goodarzi","year":"2021","journal-title":"Phytother Res"},{"issue":"5\u20136","key":"10.1016\/j.pharma.2024.02.005_bib1580","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1024\/0300-9831\/a000292","article-title":"Effects of pomegranate and orange juice on antioxidant status in non-alcoholic fatty liver disease patients: a randomized clinical trial","volume":"85","author":"Ekhlasi","year":"2015","journal-title":"Int J Vitam Nutr Res"},{"issue":"1","key":"10.1016\/j.pharma.2024.02.005_bib1585","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12906-021-03436-6","article-title":"Effect of cranberry supplementation on liver enzymes and cardiometabolic risk factors in patients with NAFLD: a randomized clinical trial","volume":"21","author":"Masnadi Shirazi","year":"2021","journal-title":"BMC Complement Med Ther"},{"issue":"8","key":"10.1016\/j.pharma.2024.02.005_bib1590","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/09637486.2020.1746957","article-title":"Combined cranberry supplementation and weight loss diet in non-alcoholic fatty liver disease: a double-blind placebo-controlled randomized clinical trial","volume":"71","author":"Hormoznejad","year":"2020","journal-title":"Int J Food Sci Nutr"},{"issue":"20","key":"10.1016\/j.pharma.2024.02.005_bib1595","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1097\/MD.0000000000000758","article-title":"A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.pharma.2024.02.005_bib1600","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1039\/c3fo60495k","article-title":"Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans","volume":"5","author":"Chang","year":"2014","journal-title":"Food Funct"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924000233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924000233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T20:12:26Z","timestamp":1713298346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450924000233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":160,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0003450924000233"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2024.02.005","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}